We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Malin Corporation Plc | LSE:0Y71 | London | Ordinary Share | IE00BVGC3741 | MALIN CORPORATION ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 0 | 12.9M | - | N/A | 0 |
TIDM0Y71
RNS Number : 5389Y
Malin Corporation PLC
09 May 2019
Board Malin Corporation plc
("Malin" or "the Company")
Board Update
Dublin-Ireland, 9 May 2019: Malin Corporation plc (Euronext Growth Dublin:MLC), a company investing in highly innovative life sciences companies, announced a board update at its Annual General Meeting held in Dublin today.
In October 2018, Mr. Ian Curley, Chairman of Malin moved into an Executive Chairman role on an interim basis, in order to support the executive management team. Mr. Curley will resume the role as Non-Executive Chairman. As the business progresses towards the previously communicated important milestones and value inflection points, the Company will seek to appoint a new Non-Executive Chairman with healthcare industry experience to further progress the business and Mr. Curley will transition off the board.
A summary of the voting results of the Annual General Meeting of the Company will be available later today on the Company's website www.malinplc.com.
ENDS
For further information, please contact:
Malin
Jessica Bergin, Director of Investor Relations & External Reporting
Tel: +353 (0)1 901 5700
investorrelations@malinplc.com
Davy Corporate Finance (Euronext Growth Adviser)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Consilium Strategic Communications
Mary-Jane Elliott / Jessica Hodgson
Tel: +44 (0)20 3709 5700
malin@consilium-comms.com
Powerscourt (Irish media enquiries)
Jack Hickey
Tel: +353 83 448 8339
malin@powerscourt-group.com
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in and supporting highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Its purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOADMGGKGLGGLZM
(END) Dow Jones Newswires
May 09, 2019 06:44 ET (10:44 GMT)
1 Year Malin Chart |
1 Month Malin Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions